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Communicated by Albert de la Chapelle 
Germinal mutations in the base excision repair (BER) gene MUTYH (MYH) have recently 
been described in association with predisposition to multiple colorectal adenomas and 
cancer. In contrast to the classic dominant condition of familial adenomatous polyposis 
(FAP) due to germinal mutations in the APC gene, the MYH polyposis is an autosomal 
recessive disease. The identification of individuals affected by MYH polyposis brings new 
and important implications for the diagnostic, screening, genetic counseling, follow up and 
therapeutic options in these patients. In this study, screening for germinal mutations in the 
MYH gene was performed in 53 Portuguese individuals with multiple colorectal adenomas 
or classic adenomatous polyposis, in whom no mutation had been identified in the APC gene. 
The results revealed the presence of biallelic germline MYH mutations in 21 patients. In 
addition, we here report 3 mutations (c.340T>C [p.Y114H]; c.503G>A [p.R168H]; and 
c.1186_1187insGG [p.E396fsX437]) which, to our knowledge, have not been previously 
described. © 2004 Wiley-Liss, Inc. 
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INTRODUCTION 
Most known inherited predispositions to colorectal tumors are dominant and include tumor-suppressor genes or 
genes of the DNA mismatch repair pathway. Recently, it was described that Mendelian recessive mutations of the 
MYH gene (MUTYH; MIM# 604933; GenBank: U63329.1, AF527839.1; GDB: 9315115)  predispose to multiple 
colorectal adenomas and carcinoma (Al-Tassan et al., 2002; Jones et al., 2002; Halford et al., 2003; Sampson et al., 
2003; Cheadle and Sampson, 2003; Sieber et al., 2003). MYH takes part in the base excision repair (BER) 
pathway, which plays a basic role in the repair of mutations caused by reactive oxygen species generated during 
the aerobic metabolism, as well as by exogenous stimuli such as ionizing radiation and various chemical oxidants. 
In man, like in bacteria and yeast, the most stable product of oxidative damage is the guanine aduct 8-oxo-7,8-
dihydroxy2'deoxyguanosine (8-oxoG), which tends to mispair with adenine, leading to G:C>T:A transversions 
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after the next DNA replication (Shibutani et al., 1991; Kasai, 1997). The critical steps in DNA repairing by BER in 
man are carried out by a set of genes, the human orthologues of  MutT, MutM and MutY in bacteria (Tajiri et al., 
1995),  that act synergistically to prevent mutagenesis induced by 8-oxoG. These are, the nucleoside 
triphosphatase hMTH1, which hydrolyses 8-oxoG-dGTP, limiting the incorporation of 8-oxo-G in DNA from the 
nucleotide pool (Sakumi et al., 1993) and the DNA glycosylases hOGG1 and hMYH (the human MutY homolog), 
which excise 8-oxoG:cytosine (Arai et al., 1997; Boiteux and Radicella, 2000) and 8-oxoG:adenine (A) 
mismatches respectively, in nascent DNA (Slupska et al., 1999; Shinmura et al., 2000). 
Al Tassan and colleagues (Al-Tassan et al., 2002) described a family in which 3 siblings with multiple colorectal 
adenomas and cancer were shown to be compound heterozygotes for mutations in the MYH gene. Later, other 
groups have confirmed the existence of biallelic germinal mutations of this gene in a large series of unrelated 
patients with multiple colorectal adenomas (Enholm et al., 2003; Halford et al., 2003; Jones et al., 2002; Sampson 
et al., 2003; Cheadle and Sampson, 2003; Sieber et al., 2003), supporting the existence of recessive MYH 
polyposis (MAP) syndrome in approximately one third of the patients with between 15 and 100 adenomas (Sieber 
et al., 2003). Two mutational hot spots were identified in the MYH gene, p.Y165C and p.G382D (Al-Tassan et al., 
2002), corresponding to approximately 78% of the mutations identified in affected Caucasians (Marra and Jiricny, 
2003).  
In this study, we examined the contribution of MYH germline mutations in a series of 53 APC mutation negative 
Portuguese patients with multiple colorectal adenomas or classic adenomatous polyposis. 
MATERIALS 
Fifty three Portuguese patients recorded in regional registries of colorectal polyposis, with multiple colorectal 
adenomas or classic adenomatous polyposis, with or without colorectal cancer (CRC), were selected for study of 
germinal mutations in the MYH gene, applying the following selection criteria: 1) no clear pathogenic germline 
mutation in the APC gene identified during genetic screening; 2) at least ten colorectal adenomas, with or without 
CRC. The clinical and family history of the selected patients is summarized in the Results and Discussion section. 
The number of adenomas was clearly specified for some patients while for others, counts were given as a range, 
e.g., <100, >100 and >1000. 
To evaluate the frequency of p.Y165C and p.G382D in the population, at least 50 Portuguese healthy individuals 
were analyzed for these mutations. 
To further characterize novel sequence variants/polymorphisms screening of at least 50 unrelated individuals of 
the Portuguese population was carried out (50 healthy and 53 affected with multiple adenomas, not pooled). 
  
METHODS 
Peripheral blood was drawn, after informed consent, from 53 unrelated Portuguese individuals. DNA was 
extracted using the Wizard DNA Extraction Kit (Promega) and the MYH gene was screened for mutations by 
SSCP.  Exons 1-16 of MYH (GenBank accession: U63329.1 and AF527839.1, where +1 corresponds to the A of 
the ATG translation initiation codon) were PCR amplified using specific exon primers published in 
http://www.uwcm.ac.uk/study/medicine/medical-genetics/research/tmg/projects/hMYH.html, combining exons as 
follows: 3&4, 5&6, 7&8, 9&10, 11&12 and 13&14. 
For the SSCP analysis (Orita et al., 1989), PCR products were separated on 6% polyacrylamide gels (acrylamide 
59: bisacrylamide 1) at 4 ºC, following denaturation.  Bands were visualized by DNA silver staining. Exons 
showing abnormal SSCP patterns were sequenced on a repeated PCR product using the automatic sequencer ABI 
Prism® 3100 Genetic analyzer (Applied Biosystems). The p.Y165C and p.G382D mutations were often 
alternatively detected by restriction fragment length polymorphism (RFLP) analysis. The wild type allele of 
p.Y165C (p.Y165) is digestible with MwoI, generating fragments of 247, 49, 43, 29 and 14 base pairs (bp), 
whereas for the mutated allele p.C165, the 247 bp fragment is digested into 175 and 72 bp. As for the wild type 
allele, p.G382, it is undigestible with BglII, but the mutated allele, p.D382, is digested to two fragments of 423 and 
82 bps. Samples with p.Y165C and p.G382D mutations, that had been previously sequenced, were also included as 
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controls. The RFLP analysis was done using 25 ul of a repeated PCR product, according to manufacturer’s 
recommendations (New England Biolabs) and analyzed in a 2.5% (wt/vol) agarose gel (Fig. 1). 
 
RESULTS AND DISCUSSION 
Biallelic germline mutations of MYH are estimated to cause 1 to 3% of unselected colorectal cancers and appear to 
be preferentially associated with multiple adenomas (Halford et al., 2003). In this study biallelic germline 
mutations in MYH were identified in 21 of 53 Portuguese patients with multiple colorectal adenomas or classic 
adenomatous polyposis, who tested negative for APC germinal mutations (Table 1). In other studies, performed in 
the same class of patients, the frequency of MYH biallelic mutation varied between 7 and 33.8 % (Sieber et al., 
2003; Sampson et al., 2003; Jones et al., 2002). Although ethnic or geographic differences cannot be excluded, the 
differences possibly reflect the criteria used in selecting patients for study (Sampson J et al., 2003; Cheadle and 
Sampson, 2003). Our results show a slightly higher overall biallelic mutation frequency (39.6%), with the 
following distribution: 10 in 26 patients without evidence for familial transmission of the disease, 9 in 15 
belonging to families with affected siblings only, in line with the autosomal recessive mode of inheritance of the 
disease and 2 in 12, of families that showed evidence for vertical transmission. In both patients one of the parents 
had died of CRC, which might be suggestive that persons carrying a single MYH mutation have a somewhat 
increased susceptibility for CRC, as has been suggested by others (Sieber et al., 2003; Enholm et al., 2003). No 
heterozygous carriers for a single MYH mutation were identified among the patients here analyzed. As found in 
other studies (Enholm et al., 2003; Sieber et al., 2003), the frequency of biallelic mutations was higher in patients 
with <100 adenomas (15/32) than in those with 100-1000 (5/19). Only two patients with >1000 adenomas were 
analyzed and one of them presented biallelic mutations. With the exception to one patient who in addition to CRC, 
also presented breast cancer, no relevant extracolonic manifestations were observed in any of the individuals found 
to be carriers of biallelic MYH mutations. 
Three novel mutations were identified in various patients, either in homozygosity or in compound heterozygosity 
with known mutations (Table 1). The frameshift mutation p.E396fsX437 (c.1186_1187insGG), which accounts for 
19% of the mutations found, was present in homozygosity in two patients from an isolate in Madeira Island and in 
one patient from the mainland and as a compound heterozygote in two others. It was not detected in the analyzed 
100 unrelated healthy individuals picked at random and not pooled (50 from Madeira Island and 50 from the 
mainland).  
As to the two other novel mutations, p.R168H (c.503G>A) was present in a patient as compound heterozygote 
with p.Y165C, while p.Y114H (c.340T>C) was found in homozygosity in both a patient and her sister both 
affected with CRC. None was found in the 50 unrelated healthy Portuguese individuals analyzed.  
Mutations p.Y114H and p.R168H consist on a change from a polar uncharged R group to a positively charged one 
and from a branched to a cyclic R group, respectively. Both mutations affect a conserved amino acid residue from 
bacteria to man. Besides, p.R168 is closely located to p.Y165, a mutation hotspot, the Bacillus stearothermophilus 
equivalent residue of which, Tyr88, is known to play a critical role in the recognition of the 8-oxoG base (Fromme 
et al., 2004).  
Further elucidation of the functional role of the altered residues, together with the analysis of other family 
members, will help to establish a more definitive correlation of these novel mutations with its mechanisms of 
pathogenicity.  
Among the 21 patients with MYH biallelic germline mutations, 10 were either homozygous or compound 
heterozygotes for the hotspot missense changes p.Y165C and p.G382D, while an additional seven patients were 
heterozygotes for one of them. Overall, the frequency of these alleles among MYH polyposis patients was 64.3%. 
For the general population, the observed frequency for p.G382D in 50 healthy individuals from Madeira Island and 
in 50 from the mainland was 1% and 2%, respectively. As for p.Y165C it was 1% in 50 healthy individuals from 
the mainland. These observations are compatible to what has been described in previous studies (Al-Tassan et al., 
2002; Jones et al., 2002; Sieber et al., 2003) and confirm that MYH mutations are not enriched in the general 
population. 
In addition, several reported and unreported polymorphisms were identified among the patients (Table 2). 
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This study contributes to support the existence of MYH polyposis syndrome and indicates that analysis of the 
MYH gene should be performed in patients with multiple colorectal adenomas, particularly in those with family 
history of horizontal transmission of the disease. On the other hand, it helped to clarify the type and frequency of 












































Figure 1. RFLP analysis for MYH p.Y165C and p.G382D using a 2.5% (wt/vol) agarose gel. The p.Y165 (wild type) allele was 
digestible with MwoI generating the fragments: 247 and 49 + 43 bps, whereas the p.C165 (mutated allele) the 247 bp fragment is
digestible into 175 and 72 bp. As for the p.G382 (wild type) allele it is undigestible with BglII but the mutated allele (p.D382) is 
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Table 1. Characteristics and Mutations in Portuguese Patients with MYH Polyposis 
Lab. # Age of Diagnosis 
Number of 
adenomas CRC Family History Biallelic MUTYH mutations
(1,2) 
0056 43 <100 Yes IC c.1145G>A p.G382D 
c.1145G>A 
p.G382D 
0197 43 >100 No Affected sister c.494A>G  p.Y165C 
c.494A>G 
p.Y165C 





0497 54 20 Yes 2 affected sisters, 1 affected niece p.E396fsX437  
c.494A>G 
p.Y165C 
0501 45 140  Yes IC c.1145G>A p.G382D 
c.494A>G 
p.Y165C 





1117 51 80-100 Yes IC c.494A>G p.Y165C 
c.503G>A 
p.R168H 
1373 57 <100 No IC  c.1186_1187insGG p.E396fsX437  
c.494A>G 
p.Y165C 
1606 50 >1000 Yes IC c.1145G>A p.G382D 
c.679C>T 
p.R227W* 
1674 47 >100 No Affected brother c.1186_1187insGG p.E396fsX437  
c.1186_1187insGG
p.E396fsX437 
2108 47 <100 No Affected brother c.1145G>A p.G382D 
c.1103delC 
p.L369fsX393 
2462 68 10 Yes Affected mother  c.1145G>A p.G382D 
c.494A>G 
p.Y165C 
2535 67 50 Yes Affected brother c.347-1G>C c.494A>G p.Y165C 
2602 50 20 Yes Affected brother c.1145G>A p.G382D 
c.1145G>A 
p.G382D 
2905 54 <100 No IC c.1186_1187insGG p.E396fsX437  
c.1186_1187insGG
p.E396fsX437 
3021 46 70 Yes Three affected brothers c.494A>G p.Y165C 
c.494A>G 
p.Y165C 
0239 50 >100 Yes  Four affected brothers c.1186_1187insGG p.E396fsX437  
c.1186_1187insGG
p.E396fsX437 
1556 36 >100 No IC  c.494A>G p.Y165C 
c.494A>G 
p.Y165C 
2358 43 70 Yes IC c.494A>G p.Y165C 
c.1145G>A 
p.G382D 
3196 37 30 No IC c.494A>G p.Y165C c.347-1G>C 





1-GenBank reference sequence MYH: U63329.1, where +1 corresponds to the A of the ATG translation initiation codon;  
2- Nomenclature according to Antonarakis et al., (1998) and den Dunnen J and Antonarakis (2000). 
IC – Index case, without evidence of family history of the disease. 
Novel mutations shown in bold.  
* Reported by Fleischmann C et al., 2004 while manuscript was under going peer review.  
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Table 2. MUTYH Polymorphism Frequencies among 53 Portuguese Patients 
Polymorphism1,2 Frequency of each allele 
c.64G>A (p.V22M) 97.73 % G and 2.27 % A 
c.972G>C  (p. Q324H) 82.60 % G and 17.40 % C 
c.1435-40G >C* 91.67 % G and 8.30 % C 
c.462+35G >A * 37.80 % G and 62.2 % A ** 
c.648+21C>A* 98.48 % C and 1.52 %A 
c.648+61T>A* 98.48  % T and 1.52 % A 
c.648+58G>A* 98.48 % G and 1.52  % A 
c.1145-57G>T* 98.48 % G and 1.52 % T 
  * Novel polymorphisms. 
  ** Only 30 patients analyzed. 
                     1-GenBank reference sequence MYH: U63329.1 and AF527839.1, where +1 corresponds to the A of   
                          the ATG translation initiation codon;                     
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